Supplements and Featured Publications
Breaking Down BTK Degraders in CLL
Volume: 1
Issue: 1
Diving Into B7-H4 Inhibition to Augment the ACC Treatment Paradigm
Volume: 1
Issue: 1
Understanding Tumor Treating Fields as a Novel Modality in Pancreatic Cancer
Volume: 1
Issue: 1
Integrating Liquid Oncolytics Into Cancer Care
Volume: 1
Issue: 1
Navigating Critical Updates in Advanced Breast Cancer Management From ASCO 2026
Volume: 1
Issue: 1
Supported in part by AstraZeneca and Daiichi Sankyo, content independently developed by OncLive.
Emerging Data Advancing Precision Medicine Across GI Malignancies From ASCO 2026
Volume: 1
Issue: 1
Assessing Recurrence Risk in Early-Stage Triple-Negative Breast Cancer
Volume: 1
Issue: 1
Treatment and Adherence Strategies in Cutaneous T-Cell Lymphoma
Volume: 1
Issue: 1
State of the Science Summit Recaps
Volume: 1
Issue: 1
Traversing Novel Allogeneic Cellular Therapy Strategies in Hematologic Oncology
Volume: 1
Issue: 1
TKI Selection and Sequencing Considerations in CML and ALL
Volume: 1
Issue: 1
2026 ASCO Genitourinary Cancers Symposium: Focus on Prostate Cancer
Volume: 1
Issue: 1
Exploring Alternate Allogeneic Immunotherapy Strategies in Hematologic Oncology
Volume: 1
Issue: 1
Practical Updates in Cutaneous Squamous Cell Carcinoma: From Disease Biology to Real-World Management
Volume: 1
Issue: 1
Exploring Immunotherapy Strategies in SCAC and MCC
Volume: 1
Issue: 1
Bridging Scientific Progress With Real-World Practice in SCLC Care
Volume: 1
Issue: 1
Personalizing Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
Volume: 1
Issue: 1
Evolving IO Management Strategies in Cutaneous Squamous Cell Carcinoma
Volume: 1
Issue: 1
Leveraging ctDNA/MRD Testing in Breast Cancer Management
Volume: 1
Issue: 1
Examining Second-Line Treatment Approaches in R/R Mantle Cell Lymphoma
Volume: 1
Issue: 1
Exploring the Role of FES-PET/CT in Breast Cancer Management
Volume: 1
Issue: 1
Exploring MRD Assessment in Lymphoma Management
Volume: 1
Issue: 1
Experts detail the exploration of minimal residual disease and the integration of ctDNA into lymphoma management.
The Evolving Role of Next-Generation Sequencing in NSCLC Management
Volume: 1
Issue: 1
Navigating Novel Allogeneic Immunotherapy Approaches in Hematologic Malignancies
Volume: 1
Issue: 1
Advancing Adjuvant Care: Exploring Oral SERDs in ER+, HER2-Negative Early Breast Cancer
Volume: 1
Issue: 1
Exploring Bispecific Approaches in Frontline Non-Hodgkin Lymphoma
Volume: 1
Issue: 1
Navigating TKI Selection in Leukemia Care
Volume: 1
Issue: 1
Traversing Key Updates in HR+ and Triple-Negative Breast Cancer
Volume: 1
Issue: 1
Exploring Novel Second- and Third-Line Approaches in Metastatic Colorectal Cancer
Volume: 1
Issue: 1
Managing LEMS in SCLC and Oncology Care
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
ctDNA MRD Status Predicts OS Benefit With Adjuvant Chemotherapy in Resected CRC Liver Metastases
2
How Bispecific T-Cell Engager Therapy Works and Why HLA Status Is Non-Negotiable
3
FDA Accepts NDA for Varegacestat in Desmoid Tumors
4
Cracking the KRAS Code: How Daraxonrasib Is Reshaping Pancreatic Cancer and Beyond
5